Quest.

Quest Diagnostics Beats Q2 Revenue, Raises Forecast

Quest Diagnostics posted Q2 2026 revenue of $3.04 billion, up 10.2% and delivering adjusted EPS of $3.12, beating expectations, and it raised its full-year outlook to roughly $11.95–$12.05 billion in revenue and $11.05–$11.25 per share in adjusted earnings amid strong demand across physician, hospital and consumer channels. The results signal sustained demand and positive momentum for diagnostic testing services, with revenue-per-requisition dynamics and volumes supporting the upgrade to guidance.